Loading...

Fariba Navid

Title(s)Associate Professor Of Clinical Pediatrics
AddressCHL 4650 Sunset Blvd
Off Campus
Los Angeles CA 90027
Phone+1 323 361 2762
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A multidisciplinary approach to management of abdominal lymphatic malformations. J Pediatr Surg. 2020 Oct 19. Zamora AK, Barry WE, Nowicki D, Ourshalimian S, Navid F, Miller JM, Zeinati C, Anselmo DM. PMID: 33526253.
      View in: PubMed   Mentions:    Fields:    
    2. Custom Pediatric Oncology Next-Generation Sequencing Panel Identifies Somatic Mosaicism in Archival Tissue and Enhances Targeted Clinical Care. Pediatr Neurol. 2020 Oct 02; 114:55-59. Quindipan C, Cotter JA, Ji J, Mitchell WG, Moke DJ, Navid F, Thomas SM, VanHirtum-Das M, Wang L, Saitta SC, Biegel JA, Hiemenz MC. PMID: 33221597.
      View in: PubMed   Mentions:    Fields:    
    3. Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours. Eur J Cancer. 2020 06; 132:35-42. Federico SM, Caldwell KJ, McCarville MB, Daryani VM, Stewart CF, Mao S, Wu J, Davidoff AM, Santana VM, Furman WL, Pappo AS, Navid F. PMID: 32325418.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    4. Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma. J Immunother Cancer. 2020 Mar; 8(1). Goldberg JL, Navid F, Hank JA, Erbe AK, Santana V, Gan J, de Bie F, Javaid AM, Hoefges A, Merdler M, Carmichael L, Kim K, Bishop MW, Meager MM, Gillies SD, Pandey JP, Sondel PM. PMID: 32169872.
      View in: PubMed   Mentions: 1     Fields:    
    5. A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors. MAbs. 2020 Jan-Dec; 12(1):1773751. Bishop MW, Hutson PR, Hank JA, Sondel PM, Furman WL, Meagher MM, Navid F, Santana VM. PMID: 32643524.
      View in: PubMed   Mentions:    Fields:    
    6. A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma. Clin Cancer Res. 2019 11 01; 25(21):6320-6328. Furman WL, Federico SM, McCarville MB, Shulkin BL, Davidoff AM, Krasin MJ, Sahr N, Sykes A, Wu J, Brennan RC, Bishop MW, Helmig S, Stewart E, Navid F, Triplett B, Santana VM, Bahrami A, Anthony G, Yu AL, Hank J, Gillies SD, Sondel PM, Leung WH, Pappo AS. PMID: 31601569.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    7. Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies. Clin Cancer Res. 2019 12 15; 25(24):7320-7330. Inaba H, Panetta JC, Pounds SB, Wang L, Li L, Navid F, Federico SM, Eisenmann ED, Vasilyeva A, Wang YD, Shurtleff S, Pui CH, Gruber TA, Ribeiro RC, Rubnitz JE, Baker SD. PMID: 31455680.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant. Cancer Genet. 2019 02; 231-232:62-66. Ji J, Navid F, Hiemenz MC, Kaneko M, Zhou S, Saitta SC, Biegel JA. PMID: 30803559.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Multi-level otsu method to define metabolic tumor volume in positron emission tomography. Am J Nucl Med Mol Imaging. 2018; 8(6):373-386. Im HJ, Solaiyappan M, Lee I, Bradshaw T, Daw NC, Navid F, Shulkin BL, Cho SY. PMID: 30697457.
      View in: PubMed   Mentions:
    10. Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab. Pediatr Blood Cancer. 2019 02; 66(2):e27487. Müller HL, Merks JHM, Geoerger B, Grill J, Hargrave D, Glade Bender J, Gururangan S, Navid F, Johnston M, Bachir J, Elze MC, Fürst-Recktenwald S. PMID: 30378286.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. The role of routine imaging in pediatric cutaneous melanoma. Pediatr Blood Cancer. 2018 12; 65(12):e27412. Halalsheh H, Kaste SC, Navid F, Bahrami A, Shulkin BL, Rao B, Kunkel M, Artz N, Pappo A. PMID: 30124237.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study. Radiology. 2018 04; 287(1):303-312. Im HJ, Zhang Y, Wu H, Wu J, Daw NC, Navid F, Shulkin BL, Cho SY. PMID: 29357275.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. Int J Cancer. 2017 10 01; 141(7):1469-1477. PMID: 28631382.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    14. 18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma. J Nucl Med. 2018 01; 59(1):25-30. PMID: 28611244.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    15. Health-Related Quality of Life and Survival Outcomes of Pediatric Patients With Nonmetastatic Osteosarcoma Treated in Countries With Different Resources. J Glob Oncol. 2018 09; 4:1-11. Bishop MW, Advani SM, Villarroel M, Billups CA, Navid F, Rivera C, Quintana JA, Gattuso JS, Hinds PS, Daw NC. PMID: 30241221.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE). Ann Am Thorac Soc. 2016 09; 13(9):1575-85. PMID: 27391297.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    17. Prospective study of neuropathic pain after definitive surgery for extremity osteosarcoma in a pediatric population. Pediatr Blood Cancer. 2017 03; 64(3). PMID: 27573717.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments. Cancer Res. 2016 07 01; 76(13):3929-41. PMID: 27197149.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    19. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Pediatr Blood Cancer. 2016 08; 63(8):1381-6. PMID: 27082077.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    20. Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control. Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):119-26. PMID: 27319287.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    21. Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma. Pediatr Blood Cancer. 2016 07; 63(7):1207-13. PMID: 27038395.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    22. Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study. AJR Am J Roentgenol. 2016 May; 206(5):933-9. PMID: 26999488.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    23. Pediatric Melanoma and Atypical Melanocytic Neoplasms. Cancer Treat Res. 2016; 167:331-69. PMID: 26601871.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. Br J Clin Pharmacol. 2016 Jan; 81(1):148-60. PMID: 26345283.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. Br J Cancer. 2015 Nov 03; 113(9):1282-8. PMID: 26461056.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    26. Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options. J Pediatr Hematol Oncol. 2015 Apr; 37(3):237-41. PMID: 25389917.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Ocular abnormalities in patients treated with a novel anti-GD2 monoclonal antibody, hu14.18K322A. J AAPOS. 2015 Apr; 19(2):112-5. PMID: 25818285.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    28. FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up. Pediatr Radiol. 2015 Aug; 45(9):1308-15. PMID: 25721584.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients. Pediatr Blood Cancer. 2015 Sep; 62(9):1518-22. PMID: 25631103.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    30. Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors. J Pediatr Surg. 2015 Sep; 50(9):1484-9. PMID: 25783402.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    31. An approach to renal masses in pediatrics. Pediatrics. 2015 Jan; 135(1):142-58. PMID: 25452658.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    32. Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma. Pediatr Blood Cancer. 2015 02; 62(2):246-251. PMID: 25381958.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma. Pediatr Blood Cancer. 2015 02; 62(2):224-228. PMID: 25382742.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    34. The genomic landscape of childhood and adolescent melanoma. J Invest Dermatol. 2015 Mar; 135(3):816-823. PMID: 25268584.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    35. Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience. AJR Am J Roentgenol. 2014 May; 202(5):966-70. PMID: 24758648.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    36. Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. J Clin Oncol. 2014 May 10; 32(14):1445-52. PMID: 24711551.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    37. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep. 2014 Apr 10; 7(1):104-12. PMID: 24703847.
      View in: PubMed   Mentions: 188     Fields:    Translation:Humans
    38. Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing. Clin Cancer Res. 2014 May 15; 20(10):2783-92. PMID: 24637635.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    39. Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study. J Am Coll Surg. 2014 Aug; 219(2):265-71. PMID: 24795268.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    40. Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery. Ann Surg Oncol. 2014 Jun; 21(6):1948-55. PMID: 24558066.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors. Invest New Drugs. 2014 Feb; 32(1):171-7. PMID: 24173965.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    42. Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma. Pediatr Blood Cancer. 2014 Feb; 61(2):373-5. PMID: 23955991.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Alternative formulations of sorafenib for use in children. Pediatr Blood Cancer. 2013 Oct; 60(10):1642-6. PMID: 23788485.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    44. Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study. J Clin Oncol. 2013 Apr 01; 31(10):1324-8. PMID: 23423746.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    45. Enhancement of the anti-melanoma response of Hu14.18K322A by aCD40 + CpG. Cancer Immunol Immunother. 2013 Apr; 62(4):665-75. PMID: 23151945.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    46. Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors. Clin Cancer Res. 2013 Jan 01; 19(1):236-46. PMID: 23143218.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    47. 64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanoma. J Nucl Med. 2012 Nov; 53(11):1772-8. PMID: 23064212.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    48. Clinical management of Ewing sarcoma of the bones of the hands and feet: a retrospective single-institution review. J Pediatr Surg. 2012 Oct; 47(10):1806-10. PMID: 23084188.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Disseminated carcinoma ex pleomorphic adenoma in an adolescent confirmed by application of PLAG1 immunohistochemistry and FISH for PLAG1 rearrangement. Head Neck Pathol. 2012 Sep; 6(3):377-83. PMID: 22297681.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Timing of surgery and the role of adjuvant radiotherapy in ewing sarcoma of the chest wall: a single-institution experience. Ann Surg Oncol. 2012 Nov; 19(12):3809-15. PMID: 22752372.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    51. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience. Ann Surg Oncol. 2012 Nov; 19(12):3816-22. PMID: 22739653.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    52. Management of melanomas in children and young adults. J Pediatr Hematol Oncol. 2012 May; 34 Suppl 2:S51-4. PMID: 22525407.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    53. Genetic alterations in childhood melanoma. Am Soc Clin Oncol Educ Book. 2012; 589-92. PMID: 24451801.
      View in: PubMed   Mentions:    Fields:    
    54. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis. 2011 Nov 15; 204(10):1475-82. PMID: 21949042.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    55. Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumors. Pediatr Blood Cancer. 2012 Mar; 58(3):372-9. PMID: 21509928.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    56. Jaw dysfunction related to pterygoid and masseter muscle dosimetry after radiation therapy in children and young adults with head-and-neck sarcomas. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):355-60. Krasin MJ, Wiese KM, Spunt SL, Hua CH, Daw N, Navid F, Davidoff AM, McGregor L, Merchant TE, Kun LE, McCrarey L, Hoth KA, Yan X, Xiong X. PMID: 21093167.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    57. Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize. Mol Cancer Res. 2010 Nov; 8(11):1489-500. PMID: 21106507.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    58. Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 01; 878(29):3033-8. Li L, Zhao M, Navid F, Pratz K, Smith BD, Rudek MA, Baker SD. PMID: 20870468.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    59. Anti-GD2 antibody therapy for GD2-expressing tumors. Curr Cancer Drug Targets. 2010 Mar; 10(2):200-9. Navid F, Santana VM, Barfield RC. PMID: 20201786.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimals
    60. Stability of cyclophosphamide in extemporaneous oral suspensions. Ann Pharmacother. 2010 Feb; 44(2):295-301. Kennedy R, Groepper D, Tagen M, Christensen R, Navid F, Gajjar A, Stewart CF. PMID: 20103616.
      View in: PubMed   Mentions:    Fields:    
    61. Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. Clin Cancer Res. 2010 Jan 15; 16(2):750-4. Jacobs S, Fox E, Krailo M, Hartley G, Navid F, Wexler L, Blaney SM, Goodwin A, Goodspeed W, Balis FM, Adamson PC, Widemann BC. PMID: 20068084.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    62. Body wall and visceral nonrhabdomyosarcoma soft tissue sarcomas in children and adolescents. J Pediatr Surg. 2009 Oct; 44(10):1965-71. Navid F, Billups CA, Krasin MJ, Davidoff AM, Harper J, Rao BN, Spunt SL. PMID: 19853756.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors. J Clin Oncol. 2009 Sep 20; 27(27):4599-604. Furman WL, Navid F, Daw NC, McCarville MB, McGregor LM, Spunt SL, Rodriguez-Galindo C, Panetta JC, Crews KR, Wu J, Gajjar AJ, Houghton PJ, Santana VM, Stewart CF. PMID: 19687340.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    64. Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):874-8. Krasin MJ, Davidoff AM, Xiong X, Wu S, Hua CH, Navid F, Rodriguez-Galindo C, Rao BN, Hoth KA, Neel MD, Merchant TE, Kun LE, Spunt SL. PMID: 19625137.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    65. Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol. 2009 Jun; 26(4):252-60. Klosky JL, Randolph ME, Navid F, Gamble HL, Spunt SL, Metzger ML, Daw N, Morris EB, Hudson MM. PMID: 19437327.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    66. Immune therapies for neuroblastoma. . 2009 May; 8(10):874-82. Navid F, Armstrong M, Barfield RC. PMID: 19342881.
      View in: PubMed   Mentions:
    67. Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer. 2008 Jul 15; 113(2):419-25. Navid F, Willert JR, McCarville MB, Furman W, Watkins A, Roberts W, Daw NC. PMID: 18484657.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    68. Stability of sunitinib in oral suspension. Ann Pharmacother. 2008 Jul; 42(7):962-6. Navid F, Christensen R, Minkin P, Stewart CF, Furman WL, Baker S. PMID: 18577759.
      View in: PubMed   Mentions: 2     Fields:    
    69. Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma. Pediatr Blood Cancer. 2008 Jun; 50(6):1147-53. Absalon MJ, McCarville MB, Liu T, Santana VM, Daw NC, Navid F. PMID: 18300316.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    70. Second cancers in patients with the Ewing sarcoma family of tumours. Eur J Cancer. 2008 May; 44(7):983-91. Navid F, Billups C, Liu T, Krasin MJ, Rodriguez-Galindo C. PMID: 18353632.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    71. Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol. 2008 Apr; 19(4):814-20. Rodríguez-Galindo C, Navid F, Liu T, Billups CA, Rao BN, Krasin MJ. PMID: 17998282.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    72. Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience. Pediatr Blood Cancer. 2007 Sep; 49(3):274-9. Saab R, Khoury JD, Krasin M, Davidoff AM, Navid F. PMID: 16685737.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    73. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer. 2007 Jul 15; 110(2):375-84. Rodríguez-Galindo C, Liu T, Krasin MJ, Wu J, Billups CA, Daw NC, Spunt SL, Rao BN, Santana VM, Navid F. PMID: 17569105.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    74. A model for quantitative changes in the magnetic resonance parameters of muscle in children after therapeutic irradiation. Magn Reson Imaging. 2006 Dec; 24(10):1319-24. Krasin MJ, Xiong X, Reddick WE, Ogg RJ, Hoffer FA, McCarville B, Kaste SC, Spunt SL, Navid F, Davidoff AM, Zhang L, Kun LE, Merchant TE. PMID: 17145403.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    75. Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. . 2006 May; 5(5):1299-308. Saab R, Bills JL, Miceli AP, Anderson CM, Khoury JD, Fry DW, Navid F, Houghton PJ, Skapek SX. PMID: 16731763.
      View in: PubMed   Mentions:
    76. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience. Cancer. 2006 Apr 15; 106(8):1846-56. Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS. PMID: 16541446.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    77. STAT3 is activated in a subset of the Ewing sarcoma family of tumours. J Pathol. 2006 Apr; 208(5):624-32. Lai R, Navid F, Rodriguez-Galindo C, Liu T, Fuller CE, Ganti R, Dien J, Dalton J, Billups C, Khoury JD. PMID: 16463269.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    78. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma. Cancer. 2005 Feb 15; 103(4):780-7. Navid F, Furman WL, Fleming M, Rao BN, Kovach S, Billups CA, Cain AM, Amonette R, Jenkins JJ, Pappo AS. PMID: 15660397.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    79. Low Dose Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Promotes Adenoviral Transduction in Human Rhabdomyosarcoma Cell Lines. Sarcoma. 2004; 8(1):25-30. Navid F, Mischen BT, Helman LJ. PMID: 18521390.
      View in: PubMed   Mentions:
    80. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat Med. 2002 Nov; 8(11):1276-80. Sharp R, Recio JA, Jhappan C, Otsuka T, Liu S, Yu Y, Liu W, Anver M, Navid F, Helman LJ, DePinho RA, Merlino G. PMID: 12368906.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    81. Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction. J Clin Oncol. 2001 Aug 15; 19(16):3649-59. Merino ME, Navid F, Christensen BL, Toretsky JA, Helman LJ, Cheung NK, Mackall CL. PMID: 11504746.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    82. Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein. Sarcoma. 2000; 4(3):93-102. Navid F, Letterio JJ, Yeung CL, Pegtel M, Helman LJ. PMID: 18521287.
      View in: PubMed   Mentions:
    83. Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia. 1999 Jan; 13(1):135-41. Navid F, Mosijczuk AD, Head DR, Borowitz MJ, Carroll AJ, Brandt JM, Link MP, Rozans MK, Thomas GA, Schwenn MR, Shields DJ, Vietti TJ, Pullen DJ. PMID: 10049049.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    84. AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma. Oncogene. 1998 Sep 10; 17(10):1261-70. Zhang L, Zhan S, Navid F, Li Q, Choi YH, Kim M, Seth P, Helman LJ. PMID: 9771969.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    85. Albumin, IgG, retinol-binding protein, and alpha1-microglobulin excretion in childhood. Pediatr Nephrol. 1998 May; 12(4):290-2. Lehrnbecher T, Greissinger S, Navid F, Pfüller H, Jeschke R. PMID: 9655359.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    Fariba's Networks
    Concepts (387)
    Derived automatically from this person's publications.
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _